Danaher Return on Tangible Equity 2012-2026 | DHR
Current and historical return on tangible equity values for Danaher (DHR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Danaher Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2026-06-30 | $4.00B | $-10.39B | -38.55% |
| 2026-03-31 | $3.69B | $-8.66B | -42.59% |
| 2025-12-31 | $3.61B | $-9.34B | -38.70% |
| 2025-09-30 | $3.50B | $-9.61B | -36.45% |
| 2025-06-30 | $3.41B | $-9.80B | -34.83% |
| 2025-03-31 | $3.77B | $-10.09B | -37.30% |
| 2024-12-31 | $3.90B | $-9.49B | -41.07% |
| 2024-09-30 | $3.89B | $-9.33B | -41.71% |
| 2024-06-30 | $4.20B | $-8.03B | -52.33% |
| 2024-03-31 | $4.40B | $-7.21B | -61.04% |
| 2023-12-31 | $4.74B | $-7.48B | -63.44% |
| 2023-09-30 | $5.87B | $-7.01B | -83.77% |
| 2023-06-30 | $6.30B | $-8.44B | -74.63% |
| 2023-03-31 | $6.85B | $-10.04B | -68.21% |
| 2022-12-31 | $7.10B | $-12.07B | -58.88% |
| 2022-09-30 | $6.64B | $-15.03B | -44.19% |
| 2022-06-30 | $6.21B | $-17.51B | -35.45% |
| 2022-03-31 | $6.29B | $-17.45B | -36.06% |
| 2021-12-31 | $6.27B | $-17.05B | -36.78% |
| 2021-09-30 | $5.72B | $-16.57B | -34.54% |
| 2021-06-30 | $5.45B | $-15.57B | -35.00% |
| 2021-03-31 | $4.60B | $-16.58B | -27.71% |
| 2020-12-31 | $3.51B | $-18.16B | -19.33% |
| 2020-09-30 | $3.57B | $-14.48B | -24.63% |
| 2020-06-30 | $3.37B | $-11.11B | -30.36% |
| 2020-03-31 | $3.19B | $-8.08B | -39.48% |
| 2019-12-31 | $2.94B | $-4.28B | -68.71% |
| 2019-09-30 | $2.43B | $-4.89B | -49.68% |
| 2019-06-30 | $2.45B | $-6.52B | -37.56% |
| 2019-03-31 | $2.41B | $-7.91B | -30.48% |
| 2018-12-31 | $2.65B | $-8.87B | -29.89% |
| 2018-09-30 | $2.76B | $-10.32B | -26.75% |
| 2018-06-30 | $2.67B | $-10.56B | -25.29% |
| 2018-03-31 | $2.55B | $-10.76B | -23.73% |
| 2017-12-31 | $2.49B | $-11.31B | -22.03% |
| 2017-09-30 | $2.38B | $-11.85B | -20.11% |
| 2017-06-30 | $2.20B | $-11.23B | -19.61% |
| 2017-03-31 | $2.30B | $-11.14B | -20.66% |
| 2016-12-31 | $2.55B | $-11.18B | -22.85% |
| 2016-09-30 | $2.50B | $-9.98B | -25.00% |
| 2016-06-30 | $3.51B | $-11.24B | -31.21% |
| 2016-03-31 | $3.55B | $-8.37B | -42.39% |
| 2015-12-31 | $3.36B | $-5.49B | -61.14% |
| 2015-09-30 | $3.33B | $-3.36B | -99.01% |
| 2015-06-30 | $2.61B | $0.45B | 581.39% |
| 2015-03-31 | $2.59B | $0.67B | 387.00% |
| 2014-12-31 | $2.60B | $1.01B | 258.41% |
| 2014-09-30 | $2.73B | $0.87B | 314.15% |
| 2014-06-30 | $2.64B | $0.21B | 1234.58% |
| 2014-03-31 | $2.58B | $-0.38B | -674.85% |
| 2013-12-31 | $2.70B | $-0.99B | -272.36% |
| 2013-09-30 | $2.54B | $-1.71B | -148.20% |
| 2013-06-30 | $2.49B | $-2.01B | -123.55% |
| 2013-03-31 | $2.47B | $-2.36B | -104.87% |
| 2012-12-31 | $2.39B | $-2.55B | -93.71% |
| 2012-09-30 | $2.33B | $-2.71B | -86.16% |
| 2012-06-30 | $2.31B | $-3.13B | -73.64% |
| 2012-03-31 | $2.36B | $-3.55B | -66.40% |
| 2011-12-31 | $2.17B | $-2.85B | -76.22% |
| 2011-09-30 | $2.08B | $-2.00B | -103.94% |
| 2011-06-30 | $2.20B | $-1.11B | -197.48% |
| 2011-03-31 | $1.92B | $-0.28B | -678.80% |
| 2010-12-31 | $1.79B | $-0.71B | -252.93% |
| 2010-09-30 | $1.59B | $-0.94B | -169.16% |
| 2010-06-30 | $1.29B | $-1.09B | -118.65% |
| 2010-03-31 | $1.21B | $-1.14B | -106.40% |
| 2009-12-31 | $1.15B | $-1.18B | -97.92% |
| 2009-09-30 | $1.19B | $-1.45B | -82.37% |
| 2009-06-30 | $1.21B | $-1.63B | -74.29% |
| 2009-03-31 | $1.28B | $-1.83B | -69.87% |
| 2008-12-31 | $1.32B | $-2.06B | -64.15% |
| 2008-09-30 | $1.33B | $-2.25B | -59.09% |
| 2008-06-30 | $1.44B | $-2.11B | -68.55% |
| 2008-03-31 | $1.39B | $-1.91B | -72.83% |
| 2007-12-31 | $1.37B | $-1.68B | -81.73% |
| 2007-09-30 | $1.37B | $-1.40B | -98.16% |
| 2007-06-30 | $1.16B | $-1.52B | -76.42% |
| 2007-03-31 | $1.16B | $-1.63B | -71.16% |
| 2006-12-31 | $1.12B | $-1.26B | -88.95% |
| 2006-09-30 | $1.05B | $-0.92B | -114.71% |
| 2006-06-30 | $1.01B | $-0.60B | -168.11% |
| 2006-03-31 | $0.93B | $-0.16B | -593.59% |
| 2005-12-31 | $0.90B | $-0.17B | -528.24% |
| 2005-09-30 | $0.86B | $-0.14B | -614.95% |
| 2005-06-30 | $0.84B | $-0.12B | -689.48% |
| 2005-03-31 | $0.79B | $-0.23B | -342.30% |
| 2004-12-31 | $0.75B | $-0.27B | -278.36% |
| 2004-09-30 | $0.70B | $-0.16B | -425.61% |
| 2004-06-30 | $0.64B | $-0.04B | -1718.92% |
| 2004-03-31 | $0.58B | $0.09B | 614.32% |
| 2003-12-31 | $0.54B | $0.16B | 343.13% |
| 2003-09-30 | $0.53B | $0.08B | 655.11% |
| 2003-06-30 | $0.51B | $-0.02B | -2933.33% |
| 2003-03-31 | $0.49B | $-0.07B | -655.41% |
| 2002-12-31 | $0.29B | $-0.12B | -243.51% |
| 2002-09-30 | $0.16B | $-0.14B | -119.12% |
| 2002-06-30 | $0.13B | $-0.09B | -142.55% |
| 2002-03-31 | $0.12B | $-0.05B | -256.99% |
| 2001-12-31 | $0.30B | $0.02B | 1589.33% |
| 2001-09-30 | $0.35B | $0.05B | 650.69% |
| 2001-06-30 | $0.35B | $0.05B | 694.53% |
| 2001-03-31 | $0.34B | $0.05B | 700.00% |
| 2000-12-31 | $0.33B | $0.09B | 351.35% |
| 2000-09-30 | $0.31B | $0.18B | 175.71% |
| 2000-06-30 | $0.29B | $0.26B | 109.37% |
| 2000-03-31 | $0.27B | $0.31B | 89.00% |
| 1999-12-31 | $0.25B | $0.28B | 91.53% |
| 1999-09-30 | $0.24B | $0.19B | 125.10% |
| 1999-06-30 | $0.20B | $0.10B | 208.70% |
| 1999-03-31 | $0.19B | $0.00B | -5938.46% |
| 1998-12-31 | $0.18B | $-0.10B | -185.24% |
| 1998-09-30 | $0.18B | $-0.10B | -176.32% |
| 1998-06-30 | $0.20B | $-0.09B | -208.51% |
| 1998-03-31 | $0.19B | $-0.04B | -500.66% |
| 1997-12-31 | $0.18B | $0.03B | 566.40% |
| 1997-09-30 | $0.16B | $0.02B | 933.33% |
| 1997-06-30 | $0.15B | $0.00B | 3650.00% |
| 1997-03-31 | $0.13B | $0.02B | 630.59% |
| 1996-12-31 | $0.21B | $0.03B | 685.25% |
| 1996-09-30 | $0.20B | $0.02B | 877.42% |
| 1996-06-30 | $0.20B | $0.03B | 710.71% |
| 1996-03-31 | $0.19B | $0.03B | 683.19% |
| 1995-12-31 | $0.11B | $0.03B | 375.65% |
| 1995-09-30 | $0.10B | $0.04B | 242.35% |
| 1995-06-30 | $0.10B | $0.07B | 137.59% |
| 1995-03-31 | $0.09B | $0.06B | 141.27% |
| 1994-12-31 | $0.08B | $0.06B | 142.61% |
| 1994-09-30 | $0.07B | $0.06B | 130.94% |
| 1994-06-30 | $0.06B | $0.04B | 162.03% |
| 1994-03-31 | $0.06B | $0.03B | 223.08% |
| 1993-12-31 | $0.02B | $0.02B | 104.62% |
| 1993-09-30 | $0.01B | $0.02B | 59.70% |
| 1993-06-30 | $0.01B | $0.02B | 31.58% |
| 1993-03-31 | $0.00B | $0.02B | 4.60% |
| 1992-12-31 | $0.03B | $0.02B | 139.13% |
| 1992-09-30 | $0.02B | $0.02B | 126.32% |
| 1992-06-30 | $0.02B | $0.01B | 146.94% |
| 1992-03-31 | $0.01B | $0.01B | 200.00% |
| 1991-12-31 | $0.01B | $0.01B | 216.67% |
| 1991-09-30 | $0.01B | $0.00B | 509.09% |
| 1991-06-30 | $0.02B | $0.00B | 733.33% |
| 1991-03-31 | $0.03B | $0.00B | 2400.00% |
| 1990-12-31 | $0.04B | 0 | 0.00% |
| 1990-09-30 | $0.06B | $0.00B | -2218.18% |
| 1990-06-30 | $0.06B | $-0.02B | -400.00% |
| 1990-03-31 | $0.06B | $-0.03B | -248.98% |
| 1989-12-31 | $0.06B | $-0.04B | -161.59% |
| 1989-09-30 | $0.05B | $-0.05B | -100.52% |
| 1989-06-30 | $0.05B | $-0.06B | -81.82% |
| 1989-03-31 | $0.05B | $-0.06B | -71.15% |
| 1988-12-31 | $0.04B | $-0.08B | -58.47% |
| 1988-09-30 | $0.03B | $-0.09B | -33.97% |
| 1988-06-30 | $0.03B | $-0.10B | -28.57% |
| 1988-03-31 | $0.02B | $-0.11B | -21.87% |
| 1987-12-31 | $0.02B | $-0.12B | -16.41% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $147.177B | $24.568B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS Health (CVS) | United States | $120.850B | 12.05 |
| HCA Healthcare (HCA) | United States | $91.758B | 14.27 |
| Elevance Health (ELV) | United States | $90.552B | 14.21 |
| Cencora (COR) | United States | $61.693B | 18.85 |
| Natera (NTRA) | United States | $50.563B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.274B | 18.52 |
| Viatris (VTRS) | United States | $19.124B | 6.61 |
| Medpace Holdings (MEDP) | United States | $17.319B | 36.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.369B | 0.00 |
| DiDi Global (DIDIY) | China | $16.046B | 176.00 |
| Revvity (RVTY) | United States | $15.643B | 26.20 |
| Solventum (SOLV) | United States | $15.330B | 12.69 |
| ICON (ICLR) | Ireland | $13.204B | 17.94 |
| Charles River Laboratories (CRL) | United States | $13.027B | 27.56 |
| BrightSpring Health Services (BTSG) | United States | $11.642B | 40.03 |
| Avantor (AVTR) | United States | $10.443B | 18.83 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.054B | 79.17 |
| HealthEquity (HQY) | United States | $7.983B | 26.01 |
| Sonic Healthcare (SKHHY) | Australia | $6.771B | 0.00 |
| PACS (PACS) | United States | $6.662B | 22.39 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.327B | 0.00 |
| MiniMed (MMED) | United States | $6.193B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.157B | 23.28 |
| Sotera Health (SHC) | United States | $5.416B | 22.33 |
| Concentras Parent (CON) | United States | $4.542B | 22.40 |
| Organon (OGN) | United States | $3.587B | 4.55 |
| GeneDx Holdings (WGS) | United States | $2.822B | 262.89 |
| CareDx (CDNA) | United States | $2.723B | 309.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.169B | 12.71 |
| Alignment Healthcare (ALHC) | United States | $2.151B | 54.58 |
| Establishment Labs Holdings (ESTA) | United States | $2.130B | 0.00 |
| Progyny (PGNY) | United States | $2.130B | 30.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.912B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.907B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.787B | 68.25 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.573B | 0.00 |
| Agilon Health (AGL) | United States | $1.547B | 0.00 |
| Ardent Health (ARDT) | United States | $1.508B | 8.62 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Nutex Health (NUTX) | United States | $1.475B | 8.45 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Omada Health (OMDA) | United States | $1.204B | 245.88 |
| GoodRx Holdings (GDRX) | United States | $1.196B | 23.27 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| CryoPort (CYRX) | United States | $0.826B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.688B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.472B | 9.77 |
| Strata Critical Medical (SRTA) | United States | $0.468B | 0.00 |
| Forward Industries (FWDI) | United States | $0.449B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.382B | 5.55 |
| Shoulder Innovations (SI) | United States | $0.374B | 0.00 |
| Biodesix (BDSX) | United States | $0.292B | 0.00 |
| Embecta (EMBC) | United States | $0.288B | 2.50 |
| So-Young (SY) | China | $0.276B | 0.00 |
| LifeMD (LFMD) | United States | $0.164B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.098B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.068B | 8.06 |
| Tevogen (TVGN) | United States | $0.050B | 0.00 |
| DocGo (DCGO) | United States | $0.038B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.008B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |